All Stories

  1. Conjugation of Functionalized Gold Nanorods and Copper (I)-Based Drug: An Anisotropic Nano Drug Delivery System
  2. Synthesis, Structural Studies, and Biological Evaluation of Copper(I) and Copper(II) Complexes Supported by Bis(pyrazol-1-yl)acetate Ligand Functionalized with Amantadine for the Treatment of Glioblastoma
  3. Synthesis, structural characterization, and investigation of anti-glioblastoma activity of copper complexes supported by bis(pyrazol-1-yl)acetate ligands functionalized with memantine
  4. Chromites in ordinary-chondrite fusion crusts
  5. New Cu(II), Cu(I) and Ag(I) Complexes of Phenoxy-Ketimine Schiff Base Ligands: Synthesis, Structures and Antibacterial Activity
  6. Anticancer potential of copper(i) complexes based on isopropyl ester derivatives of bis(pyrazol-1-yl)acetate ligands
  7. STUDY OF COPPER COMPLEXES [Cu(LCF3)2] AND [Cu(Lcur)2]H2O AS RADIOPROTECTIVE COMPOUNDS
  8. Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma
  9. Cu(I) Coordination Compounds Conjugated to Au Nanorods for Future Applications in Drug Delivery: Insights in Molecular, Electronic and Cu Local Structure in Solid and Liquid Phase
  10. Synthesis and Investigations of the Antitumor Effects of First-Row Transition Metal(II) Complexes Supported by Two Fluorinated and Non-Fluorinated β-Diketonates
  11. New Copper Complexes with N,O-Donor Ligands Based on Pyrazole Moieties Supported by 3-Substituted Acetylacetone Scaffolds
  12. INFLUENCE OF COPPER COMPLEXES [CU(PTA)4]BF4 AND [СU(ACAC)2] ON RATS IRRADIATED WITH RADIOISOTOPE TECHNETIUM
  13. Functionalized gold nanorods as drug carriers: a promising antiviral system
  14. INFLUENCE OF A COPPER(II) COMPLEX SUPPORTED BY ACETYLACETONATES ON SURVIVAL, CYTOGENETIC PARAMETERS AND BLOOD PARAMETERS OF ANIMALS WITH III-AB DEGREE BURNS
  15. Novel Silver Complexes Based on Phosphanes and Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands Targeting TrxR: New Promising Chemotherapeutic Tools Relevant to SCLC Management
  16. Copper(II) complexes based on isopropyl ester derivatives of bis(pyrazol-1-yl)acetate ligands with catalytic potency in organic macro(molecules) synthesis
  17. Synthesis and cytotoxicity studies of Cu(i) and Ag(i) complexes based on sterically hindered β-diketonates with different degrees of fluorination
  18. COMPARATIVE ANALYSIS OF TOXICITY OF BIS[BIS(3,5-DIMETHYLPYRAZOL-1-YL)ACETATO]COPPER AND CU2(3,5-DIPS)4(H2O)3 COPPER(II)-BASED COMPLEXES
  19. Exploring the Antitumor Potential of Copper Complexes Based on Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands
  20. CHANGES IN BLOOD INDICATORS IN CASE OF USE OF BIS[BIS(3,5-DIMETHYLPYRAZOL-1-YL)ACETATO]COPPER(II) COMPLEX AFTER BURN INJURIES
  21. CHANGES IN CYTOGENETIC INDICATORS PROMOTED BY THE COPPER(II) COMPLEX CU[HC(COO)(PZME2)2]2 BEFORE IRRADIATION
  22. Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects
  23. A New Dimeric Copper(II) Complex of Hexyl Bis(pyrazolyl)acetate Ligand as an Efficient Catalyst for Allylic Oxidations
  24. Zinc coordination complexes as anticancer agents
  25. INFLUENCE OF COPPER COMPLEXES [CU(PTA)4 [BF4 ] AND CU(II)2 (3,5-DIPS)4 (H2 O)3 ON THE ORGANISM OF RATS IRRADIATED WITH RADIOISOTOPE TECHNETIUM
  26. Metal Coordination Core in Copper(II) Complexes Investigated by XAFS
  27. Zinc Complexes with Nitrogen Donor Ligands as Anticancer Agents
  28. Syntheses and Reactivity of New Zwitterionic Imidazolium Trihydridoborate and Triphenylborate Species
  29. Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist
  30. EVALUATION OF PERIPHERAL BLOOD INDICATORS AND CYTOGENETIC INDICATORS USING COPPER(I) COMPLEXESFOR B
  31. Development of new and efficient copper(ii) complexes of hexyl bis(pyrazolyl)acetate ligands as catalysts for allylic oxidation
  32. Back cover
  33. CHANGES IN PERIPHERAL BLOOD AND CYTOGENETIC INDICATORS DURING THE APPLICATION OF COMPOUNDS OF THE COPPER-ORGANIC COMPLEXESTO IRRADIATIO
  34. Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications
  35. Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands
  36. Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells
  37. Phosphine–copper(I) complexes as anticancer agents: design, synthesis, and physicochemical characterization. Part I
  38. Syntheses and biological studies of nitroimidazole conjugated heteroscorpionate ligands and related Cu(I) and Cu(II) complexes
  39. New insights in Au-NHCs complexes as anticancer agents
  40. Graphical abstract TOC
  41. Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes
  42. Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity
  43. The first water-soluble copper(I) complexes bearing sulfonated imidazole- and benzimidazole-derived N-heterocyclic carbenes: Synthesis and anticancer studies
  44. Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors
  45. Novel metalloantimalarials: Transmission blocking effects of water soluble Cu(I), Ag(I) and Au(I) phosphane complexes on the murine malaria parasite Plasmodium berghei
  46. IR and Raman Spectroscopies of Inorganic, Coordination and Organometallic Compounds
  47. The hydridotris(3-nitro-1,2,4-triazol-1-yl)borate, a new nitro-substituted electron withdrawing polydentate “scorpionate”-type ligand and related copper and silver phosphane complexes
  48. The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor
  49. Recent Advances in Medicinal Applications of Coinage-Metal (Cu and Ag) N-Heterocyclic Carbene Complexes
  50. Insights into the cytotoxic activity of the phosphane copper(I) complex [Cu(thp)4][PF6]
  51. Abstracts for the Second International Meeting of the Milan Center for Neuroscience (Neuromi): Prediction and Prevention of Dementia: New Hope (Milan, July 6–8, 2016)
  52. Boron-Centered Scorpionate-Type NHC-Based Ligands and Their Metal Complexes
  53. Novel multicharged silver(I)–NHC complexes derived from zwitterionic 1,3-symmetrically and 1,3-unsymmetrically substituted imidazoles and benzimidazoles: Synthesis and cytotoxic properties
  54. Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms
  55. Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)4][PF6] with methionine-rich model peptides
  56. The Combined Therapeutical Effect of Metal-based Drugs and Radiation Therapy: The Present Status of Research
  57. In Vitroandin VivoAnticancer Activity of Copper(I) Complexes with Homoscorpionate Tridentate Tris(pyrazolyl)borate and Auxiliary Monodentate Phosphine Ligands
  58. Advances in Copper Complexes as Anticancer Agents
  59. Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes
  60. The relationship between electrospray ionization behavior and cytotoxic activity of [MI(P)4]+-type complexes (M = Cu, Ag and Au; P = tertiary phosphine)
  61. Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity
  62. Synchrotron radiation X-ray absorption spectroscopic studies in solution and electrochemistry of a nitroimidazole conjugated heteroscorpionate copper(II) complex
  63. Synthesis and Biological Activity of Ester- and Amide-Functionalized Imidazolium Salts and Related Water-Soluble Coinage Metal N-Heterocyclic Carbene Complexes
  64. A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling
  65. Biomimetic Applications of Metal Systems Supported by Scorpionates
  66. Halide and Nitrite Recognizing Hexanuclear Metallacycle Copper(II) Pyrazolates
  67. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands
  68. Front cover
  69. Silver(I) and copper(I) complexes supported by 1,3,5-triazapentadienyl ligands
  70. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(ii) complexes. Syntheses, biological activity and XAS studies
  71. A study on the coordinative versatility of new N,S-donor macrocyclic ligands: XAFS, and Cu2+ complexation thermodynamics in solution
  72. ChemInform Abstract: Chemistry and Relevant Biomimetic Applications of Group 6 Metals Systems Supported by Scorpionates
  73. Synthesis and Properties of Poly(pyrazolyl)borate and Related Boron-Centered Scorpionate Ligands. Part B: Imidazole-, Triazole- and Other Heterocycle-Based Systems
  74. Synthesis and Properties of Poly(pyrazolyl)borate and Related Boron-Centered Scorpionate Ligands. Part A: Pyrazole-Based Systems
  75. Scorpionates bearing nitro substituents: mono-, bis- and tris-(3-nitro-pyrazol-1-yl)borate ligands and their copper(i) complexes
  76. Editorial [Hot topic: “Applications of Scorpionate Ligands in Enzyme Modeling and Biological Studies” (Guest Editors: Carlo Santini and Maura Pellei)]
  77. Chemistry and Relevant Biomimetic Applications of Group 6 Metals Systems Supported by Scorpionates
  78. XAFS studies on copper(I) complexes containing scorpionate ligands
  79. Cu K-edge EXAFS on copper(I) complexes containing dihydridobis(3-nitro-1,2,4-triazol-1-yl)borate and bis(1,2,4-triazol-1-yl)acetate ligand: Evidence for the Cu–O interaction
  80. Copper(I) Isocyanide and Phosphane Complexes of Fluorinated Mono- and Bis(pyrazolyl)borates
  81. Copper Complexes as Anticancer Agents
  82. Trinuclear copper(I) complexes with triscarbene ligands: catalysis of C–N and C–C coupling reactions
  83. Sulfonate- or carboxylate-functionalized N-heterocyclic bis-carbene ligands and related water soluble silver complexes
  84. Synthesis and characterization of the copper(ii) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the64Cu complexes
  85. Copper in diseases and treatments, and copper-based anticancer strategies
  86. Novel scorpionate-type triscarbene ligands and their silver and gold complexes
  87. Unsymmetrical 3- and 5-substituted bis(pyrazolyl)borate system
  88. New homoleptic carbene transfer ligands and related coinage metal complexes
  89. Copper(I)–organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl)dithioacetate ligand
  90. Di- and tri-organotin(IV) complexes of the new bis(1-methyl-1H-imidazol-2-ylthio)acetate ligand and the decarboxylated analogues
  91. In Vitro Antitumor Activity of the Water Soluble Copper(I) Complexes Bearing the Tris(hydroxymethyl)phosphine Ligand
  92. Synthesis and spectroscopic characterization of new triorganotin(IV) complexes with the bis(1-methyl-1H-imidazol-2-ylthio)acetate ligand: effects on trout erythrocyte components
  93. Synthesis, in vitro and in vivo characterization of 64Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands
  94. Small Scorpionate Ligands:  Silver(I)-Organophosphane Complexes of 5-CF 3 -Substituted Scorpionate Ligand Combining a B−H···Ag Coordination Motif
  95. Synthesis and structural studies of a 1:2 adduct of silver(I) tetrakis(pyrazolyl)borate(III) with a tertiary phosphine
  96. Silver(I)-organophosphane complexes of the dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand. X-ray crystal structure of {[H2B(tzNO2)2]Ag[P(m-tolyl)3]2} with the scorpionate ligand co-ordinated in an unidentate κ1-N fashion
  97. Silver(i)-organophosphane complexes of electron withdrawing CF3- or NO2-substituted scorpionate ligands
  98. Synthesis, Characterization, and in Vitro Antitumor Properties of Tris(hydroxymethyl)phosphine Copper(I) Complexes Containing the New Bis(1,2,4-triazol-1-yl)acetate Ligand
  99. Synthesis and characterization of divalent metal complexes containing the heteroscorpionate ligand dihydrobis(3-carboxyethyl-5-methylpyrazolyl)borate
  100. Oxo-rhenium(V) compounds containing bis(3,5-dimethylpyrazol-1-yl)acetate scorpionate ligand
  101. Synthesis and characterization of new organotin(IV) complexes with polyfunctional ligands
  102. New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity
  103. Silver(I) poly(1,2,3-benzotriazolyl)borate complexes containing mono- and bidentate phosphine coligands
  104. Scorpionate complexes with the main group elements Ca, Ba, Sr
  105. New triorganotin(IV) complexes of a polyfunctional S,N,O-ligand
  106. Novel Rhenium(V) Oxo Complexes Containing Bis(pyrazol-1-yl)acetate and Bis(pyrazol-1-yl) Sulfonate as Tripodal N,N,O-heteroscorpionate Ligands
  107. Tin(IV) and organotin(IV) derivatives of bis(pyrazolyl)acetate: Synthesis, spectroscopic characterization and behaviour in solution.
  108. Synthesis, characterization and hydrolytic behavior of new bis(2-pyridylthio)acetate ligand and related organotin(IV) complexes
  109. Synthesis and spectroscopic characterization of new organotin(IV) complexes with bis(3,5-dimethylpyrazol-1-yl)dithioacetate
  110. Silver (I) poly(1,2,4-triazolyl)borate complexes containing monodentate phosphane ligands
  111. The First Nitro-Substituted Heteroscorpionate Ligand
  112. Silver(I) bis(1,2,4-triazolyl)borate complexes containing bidentate phosphine ligands
  113. Synthesis, spectroscopic characterization (IR,1H,13C and119Sn NMR, electrospray mass spectrometry) and toxicity of new organotin(IV) complexes withN,N′,O- andN,N′,S-scorpionate ligands
  114. Syntheses and spectroscopic and structural characterization of silver(I) complexes containing tris(isobutyl)phosphine and poly(azol-1-yl)borates
  115. A new ester substituted heteroscorpionate ligand
  116. New (diphenylphosphane)benzoic acid copper(I) derivatives of “scorpionate” ligands with superoxide scavenging activity
  117. New N,N,O,O functionalized heteroscorpionate ligands and related Zn(II) and Cd(II) derivatives
  118. Gold derivatives of scorpionates: comparison with the other coinage metal poly(pyrazolyl)borate analogues
  119. Synthesis, characterization and antioxidant activity of new copper(i) complexes of scorpionate and water soluble phosphane ligands
  120. Copper and silver derivatives of scorpionates and related ligands
  121. Crystal Structures and Vibrational and Solution and Solid-State (CPMAS) NMR Spectroscopic Studies in Triphenyl Phosphine, Arsine, and Stibine Silver(I) Bromate Systems, (R3E)xAgBrO3(E = P, As, Sb;x= 1−4)
  122. Synthesis and characterization of new copper(I) complexes containing 4-(diphenylphosphane)benzoic acid and “scorpionate” ligands with “in vitro” superoxide scavenging activity
  123. Synthesis and solution studies by electrospray mass spectroscopy of new bis(imidazolyl)borate organotin(IV) complexes
  124. Polypyrazolylborate and Scorpionate Ligands
  125. Variable Coordination Modes of NO 2 - in a Series of Ag(I) Complexes Containing Triorganophosphines, -arsines, and -stibines. Syntheses, Spectroscopic Characterization (IR, 1 H and 31 P NMR, Electrospray Ionization Mass), and Structures of [AgNO 2 (R ...
  126. Unprecedented phosphino copper(I) derivatives of tris(pyrazolyl)methanesulfonate ligand co-ordinated to metal in an unusual κ3-N,N′,O fashion
  127. Poly(1,2,3-benzotriazolyl)borate complexes with copper(I) and tri-organophosphane: an unprecedented κ1-coordination of [H2B(btz)2] (btz=1,2,3-benzotriazolyl) in the X-ray crystal structure of [Cu(PBn3)2{(btz)BH2(btz)}]
  128. Copper(i) coordination polymers and mononuclear copper(i) complexes built from poly(1,2,4-triazolyl)borate ligands and tri-organophosphinesElectronic supplementary information available: conductivity data for compounds 1–14. See http://www.rsc.org/supp...
  129. Synthesis and characterization of the first poly(imidazolyl)borate organotin(IV) complex exhibiting a polymeric chain structure
  130. The reactivity of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate (Tm) towards organotin(IV) acceptors. An unprecedented monodentate coordination mode of Tm ligand
  131. New volatile polyazolylborates of copper(I) for MOCVD
  132. Synthesis, reactivity and solid-state structural studies of new phosphino copper(I) derivatives of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate
  133. Structure and volatility of copper complexes containing pyrazolyl-based ligands
  134. Solution and solid-state structural properties of silver(I) poly(pyrazolyl)borate compounds with bidentate diphosphines
  135. Bridged poly(1-imidazolyl)borate silver(I) complexes containing tertiary mono(phosphine) ligands. The first structurally authenticated bis(imidazolyl)borate metal complex †
  136. Synthesis, characterization and X-ray structural studies of novel dinuclear silver(I) complexes of poly(azolyl)borate ligands
  137. Synthesis, structural and spectroscopic characterization of new silver(I) poly(pyrazolyl)borate complexes containing isonitrile ligands
  138. Synthesis, spectroscopic characterization, and structural systematics of new triorganophosphinecopper(I) poly(pyrazol-1-yl)borate complexes †
  139. Solution and solid-state structural properties of silver(I) dihydrobis(pyrazolyl)borate compounds with tertiary mono(phosphine) ligands †
  140. Synthesis, characterization and crystal structure of new copper(II) complexes with tris- and tetrakis-(pyrazol-1-yl)borate ligands
  141. New phosphino silver(I) derivatives of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate. X-ray crystal structure of tricyclohexylphosphinesilver(I)-hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate
  142. IR and Raman Spectroscopy of Inorganic, Coordination and Organometallic Compounds*
  143. Coordination chemistry of the sterically hindered N3-donor hydrotris(3,5-diphenylpyrazol-1-yl)borate toward silver(I)triorganophosphino compounds. Synthesis, structural and spectroscopic characterization
  144. Tin (IV) and organotin (IV) complexes containing mono or bidentate N-donor ligands. V. Imidazole and imidazoline-2-thione derivatives: synthesis and spectroscopic characterization. Comparison with other imidazole tin (IV) complexes
  145. Viscoelastic investigation by ultrasonic shear waves of liquid eutectic mixture methylurea–ammonium sulfamate
  146. Silver(I) and gold(I) complexes of hydrotris(3,5-dimethylpyrazol-1-yl)borate: synthesis, spectroscopic and structural characterization, and reactivity toward C-, N- and S-donor ligands.
  147. Syntheses and Spectroscopic and Structural Characterization of Silver(I) Complexes Containing Tertiary Phosphines and Hydrotris(pyrazol-1-yl)-, Hydrotris(4-bromopyrazol-1-yl)-, Hydrotris(3,5-dimethypyrazol-1-yl)-, and Hydrotris(3-methyl-2-thioxo-1-imid...
  148. Metal polypyrazolylborates
  149. Variable co-ordination numbers in 1∶1 adducts of silver(I) tetrakis(pyrazolyl)borates with tertiary phosphines
  150. Tin(IV) and organotin(IV) complexes containing mono or bidentate N-donor ligands—IV. 2-methyl-, 2-isopropyl- and 4-methyl-imidazole derivatives: synthesis, characterization and behaviour in solution
  151. Tris(4-bromo-1H-pyrazol-1-yl)borato derivatives of first-row transition and group 12 and 14 metals. X-ray crystal structure of [HB(4-Brpz)3]2 Cd. 113Cd solution NMR study of bis[poly(pyrazolyl)borato]cadmium complexes
  152. Synthesis and characterization of copper(I) derivatives with N-donor ligands—IV. Poly (1H-pyrazol-1-yl)borates cyclohexylphosphine CuI, the X-ray crystal structures of [HB-(μ-pz)3-CuP(Cy)3] and [HB-(μ-3,5 Me2pz)3-CuP(Cy)3]
  153. Zinc(II), cadmium(II) and mercury(II) derivatives of bis(4-halopyrazol-1-yl)alkanes: synthesis, spectroscopic characterization and behaviour in solution
  154. Organotin(IV) polypyrazolylborates. XII. Hydridotris(4-bromo-1H-pyrazol-1-yl) borates: characterization, Mössbauer study and X-ray crystal structure of MeCl2Sn(4-BrPz)3BH
  155. Metal polypyrazolylborates. X. Thienylmercury(II) derivatives: the X-ray crystal structure of [(5-Me) Thien-2-yl]Hg-(ν-Pz)2B(Pz)2
  156. Organotin(IV) polypyrazolylborates. IX. Tetrakis(4-methyl-1 H-pyrazol-l-yl)borates. Characterisation, Mössbauer study and X-ray crystal structure of Cl3Sn(μ-4-MePz)3B(4-MePz)
  157. Trichloro-, mono-, di- and tri-organotin(IV) derivatives of hydridotris(4-methylpyrazol-1-yl)borates
  158. Synthesis and characterization of some zinc, cadmium and mercury(II) derivatives of bis(4-methylpyrazol-1-yl) alkanes